Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome

Journal of Neuroscience

Volumn 33, Issue 25, 2013, Pages 10559-10567

  Tarr, Tyler B ^a   Malick, Waqas ^a   Liang, Mary ^b   Valdomir, Guillermo ^b   Frasso, Michael ^b   Lacomis, David ^b   Reddel, Stephen W ^c   Garcia Ocano, Adolfo ^a   Wipf, Peter ^b   Meriney, Stephen D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; CYCLIN DEPENDENT KINASE; GV 58; ROSCOVITINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; HUMAN; IC 50; INTRACELLULAR RECORDING; MOUSE; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; ROOM TEMPERATURE;

ACTION POTENTIALS; ADULT; AGED; ANIMALS; CALCIUM CHANNEL AGONISTS; CELL LINE; CYCLIN-DEPENDENT KINASES; DATA INTERPRETATION, STATISTICAL; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MICE; MICE, TRANSGENIC; MIDDLE AGED; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; PHOSPHOTRANSFERASES; PURINES; THIOPHENES;

EID: 84879174996     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4629-12.2013     Document Type: Article

References (52)

1. Bradley SA, Lyons PR, Slater CR (1989) The epitrochleoanconeus muscles (ETA) of the mouse: a useful muscle for the study of motor innervation. J Physiol 415:3P.
2. Buraei Z, Anghelescu M, Elmslie KS (2005) Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine. Biophys J 89:1681-1691. CrossRef Medline
3. Buraei Z, Schofield G, Elmslie KS (2007) Roscovitine differentially affects CaV2 and Kv channels by binding to the open state. Neuropharmacology 52:883-894. CrossRef Medline
4. Chen J, Billings SE, Nishimune H (2011) Calcium channels link the musclederived synapse organizer laminin β2 to Bassoon and CAST/Erc2 to organize presynaptic active zones. J Neurosci 31:512-525. CrossRef Medline
5. Chen J, Mizushige T, Nishimune H (2012) Active zone density is conserved during synaptic growth but impaired in aged mice. J Comp Neurol 520: 434-452. CrossRef Medline
6. Cho S, Meriney SD (2006) The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction. Eur J Neurosci 23:3200-3208. CrossRef Medline
7. Church PJ, Stanley EF (1996) Single L-type calcium channel conductance with physiological levels of calcium in chick ciliary ganglion neurons. J Physiol 496:59-68. Medline
8. De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH (1997) Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518-526. CrossRef Medline
9. DeStefino NR, Pilato AA, Dittrich M, Cherry SV, Cho S, Stiles JR, Meriney SD (2010) (R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents. Neuroscience 167:838-849. CrossRef Medline
10. Eggermann E, Bucurenciu I, Goswami SP, Jonas P (2012) Nanodomain coupling between Ca(2) channels and sensors of exocytosis at fast mammalian synapses. Nat Rev Neurosci 13:7-21. CrossRef Medline
11. Flink MT, Atchison WD (2002) Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J Physiol 543:567-576. CrossRef Medline
12. Fu AK, Ip FC, Fu WY, Cheung J, Wang JH, Yung WH, Ip NY (2005) Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc Natl Acad Sci USA 102:15224-15229. CrossRef Medline
13. Fukunaga H, Engel AG, Lang B, Newsom-Davis J, Vincent A (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A 80:7636-7640. CrossRef Medline
14. Fukuoka T, Engel AG, Lang B, Newsom-Davis J, Vincent A (1987) Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate. Ann Neurol 22:200-211. CrossRef Medline
15. Gaffield MA, Tabares L, Betz WJ (2009) The spatial pattern of exocytosis and postexocytic mobility of synaptopHluorin in mouse motor nerve terminals. J Physiol 587:1187-1200. CrossRef Medline
16. Hess P, Lansman JB, Tsien RW (1984) Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311:538-544. CrossRef Medline
17. Katz E, Ferro PA, Weisz G, Uchitel OD (1996) Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J Physiol 497:687-697. Medline
18. Kennedy HJ, Pouli AE, Ainscow EK, Jouaville LS, Rizzuto R, Rutter GA (1999) Glucose generates subplasma membrane ATP microdomains in single islet beta-cells: potential role for strategically located mitochondria. J Biol Chem 274:13281-13291. CrossRef Medline
19. Kim SH, Ryan TA (2010) CDK5 serves as a major control point in neurotransmitter release. Neuron 67:797-809. CrossRef Medline
20. Lambert EH, Eaton LM, Rooke ED (1956) Defect of neuromuscular conduction associated with malignant neoplasm. Am J Physiol 187:612-613.
21. Lang B, Molenaar PC, Newsom-Davis J, Vincent A (1984) Passive transfer of Lambert-Eaton myasthenic syndrome in mice: decreased rates of resting and evoked release of acetylcholine from skeletal muscle. J Neurochem 42:658-662. CrossRef Medline
22. Liang M, Tarr TB, Bravo-Altamirano K, Valdomir G, Rensch G, Swanson L, DeStefino NR, Mazzarisi CM, Olszewski RA, Wilson GM, Meriney SD, Wipf P (2012) Synthesis and biological evaluation of a selective N-and P/Q-type calcium channel agonist. ACS Med Chem Lett 3:985-990. CrossRef
23. Luo F, Dittrich M, Stiles JR, Meriney SD (2011) Single-pixel optical fluctuation analysis of calcium channel function in active zones of motor nerve terminals. J Neurosci 31:11268-11281. CrossRef Medline
24. Maechler P, Wang H, Wollheim CB (1998) Continuous monitoring of ATP levels in living insulin secreting cells expressing cytosolic firefly luciferase. FEBS Lett 422:328-332. CrossRef Medline
25. McLachlan EM, Martin AR (1981) Non-linear summation of end-plate potentials in the frog and mouse. J Physiol 311:307-324. Medline
26. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536. CrossRef Medline
27. Mori S, Kishi M, Kubo S, Akiyoshi T, Yamada S, Miyazaki T, Konishi T, Maruyama N, Shigemoto K (2012) 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis. J Neuroimmunol 245:75-78. CrossRef Medline
28. Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD (2013) Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. J Physiol 591:2747-2762. CrossRef Medline
29. Nagwaney S, Harlow ML, Jung JH, Szule JA, Ress D, Xu J, Marshall RM, McMahan UJ (2009) Macromolecular connections of active zone material to docked synaptic vesicles and presynaptic membrane at neuromuscular junctions of mouse. J Comp Neurol 513:457-468. CrossRef Medline
30. Nishimune H, Sanes JR, Carlson SS (2004) A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432:580-587. CrossRef Medline
31. Oh SJ, Hatanaka Y, Claussen GC, Sher E (2007) Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome. Muscle Nerve 35:178-183. CrossRef Medline
32. Oh SJ, Claussen GG, Hatanaka Y, Morgan MB (2009) 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS. Muscle Nerve 40:795-800. CrossRef Medline
33. Rogozhin AA, Pang KK, Bukharaeva E, Young C, Slater CR (2008) Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. J Physiol 586:3163-3182. CrossRef Medline
34. Ruiz R, Cano R, Casañas JJ, Gaffield MA, Betz WJ, Tabares L (2011) Active zones and the readily releasable pool of synaptic vesicles at the neuromuscular junction of the mouse. J Neurosci 31:2000-2008. CrossRef Medline
35. Schara U, Della Marina A, Abicht A (2012) Congenital myasthenic syndromes: current diagnostic and therapeutic approaches. Neuropediatrics 43:184-193. CrossRef Medline
36. Smith DO, Conklin MW, Jensen PJ, Atchison WD (1995) Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol 487:115-123. Medline
37. Tarr TB, Dittrich M, Meriney SD (2013) Are unreliable release mechanisms conserved from NMJ to CNS? Trends Neurosci 36:14-22. CrossRef Medline
38. Tavalin SJ, Shepherd D, Cloues RK, Bowden SE, Marrion NV (2004) Modulation of single channels underlying hippocampal L-type current enhancement by agonists depends on the permeant ion. J Neurophysiol 92:824-837. CrossRef Medline
39. Titulaer MJ, Lang B, Verschuuren JJ (2011a) Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10:1098-1107. CrossRef Medline
40. Titulaer MJ, Maddison P, Sont JK, Wirtz PW, Hilton-Jones D, Klooster R, Willcox N, Potman M, Sillevis Smitt PA, Kuks JB, Roep BO, Vincent A, van der Maarel SM, van Dijk JG, Lang B, Verschuuren JJ (2011b) Clinical Dutch-English Lambert-Eaton myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol 29:902-908. CrossRef Medline
41. 2+ channels. Proc Natl Acad Sci U S A 100:3491-3496. CrossRef Medline
42. Verschuuren JJ, Wirtz PW, Titulaer MJ, Willems LN, van Gerven J (2006) Available treatment options for the management of Lambert-Eaton myasthenic syndrome. Expert Opin Pharmacother 7:1323-1336. CrossRef Medline
43. Veseleý J, Havlicek L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, Meijer L (1994) Inhibition of cyclindependent kinases by purine analogues. Eur J Biochem 224:771-786. CrossRef Medline
44. Vincent A, Lang B, Newsom-Davis J (1989) Autoimmunity to the voltagegated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 12:496-502. CrossRef Medline
45. Wachman ES, Poage RE, Stiles JR, Farkas DL, Meriney SD (2004) Spatial distribution of calcium entry evoked by single action potentials within the presynaptic active zone. J Neurosci 24:2877-2885. CrossRef Medline
46. White MG, Crumling MA, Meriney SD (1997) Developmental changes in calcium current pharmacology and somatostatin inhibition in chick parasympathetic neurons. J Neurosci 17:6302-6313. Medline
47. Wirtz PW, Verschuuren JJ, van Dijk JG, de Kam ML, Schoemaker RC, van Hasselt JG, Titulaer MJ, Tjaden UR, den Hartigh J, van Gerven JM (2009) Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. Clin Pharmacol Ther 86:44-48. CrossRef Medline
48. Wyatt RM, Balice-Gordon RJ (2008) Heterogeneity in synaptic vesicle release at neuromuscular synapses of mice expressing synaptopHluorin. J Neurosci 28:325-335. CrossRef Medline
49. Xu YF, Hewett SJ, Atchison WD (1998) Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals. J Neurophysiol 80:1056-1069. Medline
50. Yan Z, Chi P, Bibb JA, Ryan TA, Greengard P (2002) Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol 540:761-770. CrossRef Medline
51. Yazejian B, DiGregorio DA, Vergara JL, Poage RE, Meriney SD, Grinnell AD (1997) Direct measurements of presynaptic calcium and calciumactivated potassium currents regulating neurotransmitter release at cultured Xenopus nerve-muscle synapses. J Neurosci 17:2990-3001. Medline
52. 2+ channel activator, in cardiac and vascular preparations. Mol Pharmacol 40:734-741. Medline